Asia
Calcium iodide prices in Asia continued with a stable trend in Q4’25. The consistent demand from pharmaceutical and nutraceutical sectors remained unchanged, particularly for the use in thyroid and water treatment segments. The supply remained consistent, with a smooth supply chain from major countries like China and India. The costs of raw materials showed a slight increase during the quarter, which provided a moderate upward support. The buying pattern remained cautious, with a focus on meeting immediate needs rather than building inventory levels. The supply chain showed improvements compared to earlier months, and the Asian market recorded a healthy balance with moderate upward support.
Europe
In Europe, calcium iodide prices were mostly steady with a slight increase over the quarter. Domestic demand from pharmaceutical and supplement manufacturers remained regular, supporting the market. Import activity from Asia influenced pricing, as higher global iodine costs slightly lifted local prices. Production and supply were consistent, though occasional delays created minor fluctuations. Buyers maintained careful procurement, avoiding large restocking, which helped keep the market calm. Overall, the European market showed a cautious but balanced trend.
North America
In the North American region, the prices of calcium iodide were stable throughout Q4’25. However, the demand from the healthcare, nutraceutical, and industrial segments was moderate. Imports from Asian countries like China, India, and Japan were smooth, ensuring the supply of the material. Although the prices of raw materials were volatile, they were stable. Routine buying activities were seen, and the supplies were adequate. Overall, the market was stable, with some fluctuations due to minor changes in the supply chain.